These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 28013036)

  • 1. The Involvement of Hepatocyte Growth Factor-MET-Matrix Metalloproteinase 1 Signaling in Bladder Cancer Invasiveness and Proliferation. Effect of the MET Inhibitor, Cabozantinib (XL184), on Bladder Cancer Cells.
    Shintani T; Kusuhara Y; Daizumoto K; Dondoo TO; Yamamoto H; Mori H; Fukawa T; Nakatsuji H; Fukumori T; Takahashi M; Kanayama H
    Urology; 2017 Mar; 101():169.e7-169.e13. PubMed ID: 28013036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models.
    Sameni M; Tovar EA; Essenburg CJ; Chalasani A; Linklater ES; Borgman A; Cherba DM; Anbalagan A; Winn ME; Graveel CR; Sloane BF
    Clin Cancer Res; 2016 Feb; 22(4):923-34. PubMed ID: 26432786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of hepatocyte growth factor on invasion of ovarian cancer cell line SKOV3 and its signal transduction pathway].
    Wang HL; Zhang SL; Lu YM; Jiang JY; Zhu XY
    Ai Zheng; 2006 May; 25(5):570-5. PubMed ID: 16687076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual inhibition using cabozantinib overcomes HGF/MET signaling mediated resistance to pan-VEGFR inhibition in orthotopic and metastatic neuroblastoma tumors.
    Daudigeos-Dubus E; Le Dret L; Bawa O; Opolon P; Vievard A; Villa I; Bosq J; Vassal G; Geoerger B
    Int J Oncol; 2017 Jan; 50(1):203-211. PubMed ID: 27922668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cabozantinib suppresses tumor growth and metastasis in hepatocellular carcinoma by a dual blockade of VEGFR2 and MET.
    Xiang Q; Chen W; Ren M; Wang J; Zhang H; Deng DY; Zhang L; Shang C; Chen Y
    Clin Cancer Res; 2014 Jun; 20(11):2959-70. PubMed ID: 24700742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c-Met pathway.
    Ide T; Kitajima Y; Miyoshi A; Ohtsuka T; Mitsuno M; Ohtaka K; Koga Y; Miyazaki K
    Int J Cancer; 2006 Dec; 119(12):2750-9. PubMed ID: 16998831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low dose geldanamycin inhibits hepatocyte growth factor and hypoxia-stimulated invasion of cancer cells.
    Koga F; Tsutsumi S; Neckers LM
    Cell Cycle; 2007 Jun; 6(11):1393-402. PubMed ID: 17525527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated MET is a molecular prognosticator and potential therapeutic target for malignant peripheral nerve sheath tumors.
    Torres KE; Zhu QS; Bill K; Lopez G; Ghadimi MP; Xie X; Young ED; Liu J; Nguyen T; Bolshakov S; Belousov R; Wang S; Lahat G; Liu J; Hernandez B; Lazar AJ; Lev D
    Clin Cancer Res; 2011 Jun; 17(12):3943-55. PubMed ID: 21540237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recruited T cells promote the bladder cancer metastasis via up-regulation of the estrogen receptor β/IL-1/c-MET signals.
    Tao L; Qiu J; Slavin S; Ou Z; Liu Z; Ge J; Zuo L; Guancial EA; Messing EM; Chang C; Yeh S
    Cancer Lett; 2018 Aug; 430():215-223. PubMed ID: 29684419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 14-3-3 Sigma Protein Contributes to Hepatocyte Growth Factor-mediated Cell Proliferation and Invasion
    Jung JY; Koh SA; Lee KH; Kim JR
    Anticancer Res; 2022 Jan; 42(1):519-530. PubMed ID: 34969762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1.
    Jiang Y; Xu W; Lu J; He F; Yang X
    Biochem Biophys Res Commun; 2001 Sep; 286(5):1123-30. PubMed ID: 11527416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
    Kim CH; Kim J; Kahng H; Choi EC
    Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional expression of HGF and its receptor in human colorectal cancer.
    Otte JM; Schmitz F; Kiehne K; Stechele HU; Banasiewicz T; Krokowicz P; Nakamura T; Fölsch UR; Herzig K
    Digestion; 2000; 61(4):237-46. PubMed ID: 10878450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells.
    Parr C; Jiang WG
    Int J Oncol; 2001 Oct; 19(4):857-63. PubMed ID: 11562767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
    Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor is an invasion/migration factor of rat urothelial carcinoma cells in vitro.
    Tamatani T; Hattori K; Iyer A; Tamatani K; Oyasu R
    Carcinogenesis; 1999 Jun; 20(6):957-62. PubMed ID: 10357773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Green tea (-)-epigallocatechin-3-gallate inhibits HGF-induced progression in oral cavity cancer through suppression of HGF/c-Met.
    Koh YW; Choi EC; Kang SU; Hwang HS; Lee MH; Pyun J; Park R; Lee Y; Kim CH
    J Nutr Biochem; 2011 Nov; 22(11):1074-83. PubMed ID: 21292466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting MACC1 by RNA interference inhibits proliferation and invasion of bladder urothelial carcinoma in T24 cells.
    Xu ST; Ding X; Ni QF; Jin SJ
    Int J Clin Exp Pathol; 2015; 8(7):7937-44. PubMed ID: 26339359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth.
    Yakes FM; Chen J; Tan J; Yamaguchi K; Shi Y; Yu P; Qian F; Chu F; Bentzien F; Cancilla B; Orf J; You A; Laird AD; Engst S; Lee L; Lesch J; Chou YC; Joly AH
    Mol Cancer Ther; 2011 Dec; 10(12):2298-308. PubMed ID: 21926191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin α6β4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF).
    Carpenter BL; Chen M; Knifley T; Davis KA; Harrison SMW; Stewart RL; O'Connor KL
    J Biol Chem; 2015 Nov; 290(45):27228-27238. PubMed ID: 26381405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.